Physician profile
Enrique Esnard
NPI 1366670143
$3,608.56
in general payments reported to CMS, 2019-2025
8 companies · $144 in 2025
The $144 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,574 · 2021: $147 · 2022: $1,303 · 2023: $53.27 · 2024: $388 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $347 · Travel and Lodging: $238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $346.81 |
| Travel and Lodging | $237.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,592.23 | 2019-2024 | Vercise |
| Medtronic USA, INC. | $400.14 | 2019 | |
| Biogen, INC. | $166.35 | 2022-2024 | Vumerity |
| Medtronic, INC. | $137.16 | 2021-2025 | Percept PC Brainsense |
| Eisai INC. | $125.00 | 2025 | |
| Livanova USA, INC. | $103.94 | 2019-2023 | Vns Therapy Sentiva Model 1000 Generator |
| Argenx US, INC. | $69.84 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $13.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Enrique Esnard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.